GOSS
Gossamer Bio Inc
10.90$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.2% | 98.3% | 98.4% | 99.3% | 98.1% | 98.3% | 98.2% | 97.9% | 97.7% | 97.3% | 96.6% | 94.6% | |
| 23.7% | 10.3% | 15.0% | 23.3% | 8.1% | 14.6% | 10.3% | 10.9% | 4.3% | 21.9% | 31.8% | 53.5% | |
| 94.5% | 95.0% | 94.2% | 94.9% | 93.2% | 93.4% | 91.9% | 88.4% | 86.3% | 79.5% | 77.0% | 74.2% | |
| – | – | – | 1.0% | 1.9% | 1.7% | 2.3% | 3.3% | 4.6% | 7.3% | 7.3% | 7.9% | |
| 69.9% | 79.9% | 89.7% | 78.2% | 84.6% | 90.6% | 102.2% | 119.1% | 139.4% | 171.3% | 225.3% | 222.3% | |
| 12.2% | 16.5% | 13.8% | 12.1% | 14.6% | 14.3% | 17.2% | 22.2% | 29.7% | 36.8% | 43.8% | 179.2% | |
| 4.3% | 4.8% | 4.7% | 0.5% | 0.5% | 0.3% | 0.3% | 0.4% | 0.4% | 0.5% | 0.7% | 47.0% | |
| 0.4% | 1.8% | 1.0% | 0.3% | 0.9% | 0.7% | 1.2% | 0.8% | 0.5% | 3.5% | 8.4% | 7.7% | |
| 57.5% | 63.3% | 75.9% | 52.8% | 56.2% | 62.6% | 70.5% | 82.2% | 94.9% | 115.2% | 154.2% | – | |
| 30.1% | 20.1% | 10.3% | 21.8% | 15.4% | 9.4% | -2.2% | -19.1% | -39.4% | -71.3% | -125.3% | -122.3% | |
| -334.5% | -388.6% | -483.5% | -322.6% | -352.1% | -402.3% | -465.2% | -557.6% | -666.5% | -835.4% | -1,152.5% | -1,910.7% | |
| 55.4% | 72.3% | 87.0% | 63.9% | 64.5% | 71.9% | 80.8% | 94.3% | 1.4% | 1.6% | 2.3% | 5.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.